WHIP-180

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameWHIP-180
Drug Alias NameWHI-P180
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMast cells inhibitorsCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsFood HypersensitivityUrticariaRhinitis, Allergic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWayne Hughes Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransition Therapeutics IncWayne Hughes Institute
Active IndicationsN/A
Inactive IndicationsFood HypersensitivityUrticariaRhinitis, Allergic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A